DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
We observed previously that combined small interfering RNAs (siRNAs) targeting CrkII and CrkL, known activators of guanine nucleotide exchange factor DOCK1, strongly inhibit Caco-2 intestinal epithelial cell spreading and migration on collagen IV. DOCK1 siRNA reduced its expression >95% in Caco-2 cells but inhibited spreading much less than combined CrkII/CrkL siRNAs, suggesting that CrkII/CrkL interact with additional DOCK proteins. siRNA targeting DOCK5, a closely related DOCK1 family member, inhibited Caco-2 spreading similarly to DOCK1 siRNA, and the combined siRNAs synergistically inhibited spreading. Similar results were observed in human umbilical vein endothelial cells, and reverse transcriptase PCR demonstrated DOCK5 siRNA reduction of DOCK5 expression in both cell types. Combined DOCK1/DOCK5 siRNAs also inhibited Caco-2 migration and lamellipodial extension. Expression of DOCK5 cDNA, with silent mutations in the siRNA target region allowing expression simultaneously with DOCK5 siRNA, required CrkII/CrkL to restore cell spreading and DOCK5 coimmunoprecipitated with CrkII and CrkL. DOCK5 association with CrkII and CrkL was greatly reduced by mutations in their NH2-terminal SH3 domains. Expression of the DOCK5 COOH-terminal region (Met1738-Gln1870), containing potential Src homology 3 domain-binding proline-rich sites but lacking other functional regions, inhibited Caco-2 spreading and coimmunoprecipitated with CrkL. Coimmunoprecipitation of full-length DOCK5 with CrkL was strongly reduced by deletion of DOCK5 COOH-terminal amino acids 1832-1870. Green fluorescent protein-tagged DOCK5 localized to the membrane of Caco-2 cells spreading on collagen IV. In these studies, we describe human DOCK5 cloning and expression, our results indicating that, along with DOCK1, DOCK5 is an important mediator of CrkII/CrkL regulation of Caco-2 spreading and migration on collagen IV.
Sanders
Matthew A
MA
Research Service and Surgical Service, John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan 48201-1932 and the Department of Surgery, Wayne State University, Detroit, Michigan 48201; Research Service and Surgical Service, John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan 48201-1932 and the Department of Surgery, Wayne State University, Detroit, Michigan 48201. Electronic address: matt.sanders2@gmail.com.
Ampasala
Dinakar
D
Research Service and Surgical Service, John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan 48201-1932 and the Department of Surgery, Wayne State University, Detroit, Michigan 48201; Research Service and Surgical Service, John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan 48201-1932 and the Department of Surgery, Wayne State University, Detroit, Michigan 48201.
Basson
Marc D
MD
Research Service and Surgical Service, John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan 48201-1932 and the Department of Surgery, Wayne State University, Detroit, Michigan 48201; Research Service and Surgical Service, John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan 48201-1932 and the Department of Surgery, Wayne State University, Detroit, Michigan 48201.
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism; D018938:Caco-2 Cells; D002465:Cell Movement / Q000502:physiology*; D024141:Collagen Type IV; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology / Q000378:metabolism*; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism; D011485:Protein Binding / Q000502:physiology; D017434:Protein Structure, Tertiary / Q000502:physiology; D050737:Proto-Oncogene Proteins c-crk / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D020744:rac GTP-Binding Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
D048868:Adaptor Proteins, Signal Transducing; C082869:CRKL protein; D024141:Collagen Type IV; C099818:DOCK1 protein, human; D009687:Nuclear Proteins; D050737:Proto-Oncogene Proteins c-crk; D034741:RNA, Small Interfering; D020744:rac GTP-Binding Proteins